LOXL1 and neoplasm: In these groups several noteworthy changes include the ECM cross-linking proteins, lysyl oxidase, lysyl oxidase-like 1, and tissue transglutaminase II (TGM2), which have been previously shown to play a role in tumor stiffness and progression22–24.